Streetbeat News

Analyst Ratings

GENK

Craig-Hallum analyst Jeremy Hamblin has maintained a Buy rating on GEN Restaurant Group (NASDAQ:GENK) but lowered the price target from $27 to $16. This adjustment reflects a more conservative valuation of the company's future prospects.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 7:03 pm

HLVX

Guggenheim analyst Seamus Fernandez has maintained a Buy rating on HilleVax (NASDAQ:HLVX) but reduced the price target from $38 to $34.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 7:02 pm

QUIK

Craig-Hallum analyst Richard Shannon has maintained a Buy rating on QuickLogic (NASDAQ:QUIK) and increased the price target from $11 to $13.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 7:01 pm

PDSB

Over the past 3 months, 4 Wall Street analysts have provided ratings on PDS Biotechnology (NASDAQ:PDSB) with 3 bullish and 1 somewhat bullish, and no bearish ratings. The average price target is $20.75, which is significantly higher than the current price of $6.29. This target has decreased by 9.78% from the previous target of $23.00.

Portfolio Pulse from Benzinga Insights

November 15, 2023 | 7:01 pm

GL

Globe Life (NYSE:GL) received 6 analyst ratings in the last quarter with an average price target of $135.0, representing an upside from the current price of $117.6. The ratings included 1 bullish, 2 somewhat bullish, and 3 indifferent, with no bearish or somewhat bearish ratings. The current average price target has increased by 5.97% from the previous target of $127.40. Analysts typically review stocks each quarter and may adjust their ratings based on financial analysis and company performance.

Portfolio Pulse from Benzinga Insights

November 15, 2023 | 7:00 pm

GPCR

Structure Therapeutics (NASDAQ:GPCR) received 6 analyst ratings in the last quarter, with an average price target of $88.17, representing significant upside from the current price of $50.4. The consensus among analysts is positive, with 1 bullish and 5 somewhat bullish ratings. The average price target has increased by 48.94% from the previous target of $59.20.

Portfolio Pulse from Benzinga Insights

November 15, 2023 | 7:00 pm

HD

Guggenheim analyst Steven Forbes has maintained a Buy rating on Home Depot (NYSE:HD) but has reduced the price target from $360 to $340.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 7:00 pm

FHN

Analysts have provided ratings for First Horizon (NYSE:FHN) with 0 bullish, 2 somewhat bullish, 5 indifferent, and no bearish ratings in the last quarter. The average price target is $13.07, which is an upside from the current price of $12.445. This target has decreased by 0.98% from the previous target of $13.20. Analysts typically review stocks quarterly or after major company updates, considering financials, meetings, and insider communications.

Portfolio Pulse from Benzinga Insights

November 15, 2023 | 7:00 pm

WES

Over the past 3 months, 5 analysts have provided their opinions on Western Midstream (NYSE:WES) stock, with 1 bullish, 2 somewhat bullish, and 2 indifferent ratings. The average 12-month price target among these analysts is $31.6, with a high of $35.00 and a low of $27.00. This target remains unchanged from the previous average. Analyst ratings are based on research and are updated typically once per quarter.

Portfolio Pulse from Benzinga Insights

November 15, 2023 | 7:00 pm

OMF

OneMain Holdings (NYSE:OMF) has received mixed ratings from analysts in the last quarter, with 1 bullish, 5 somewhat bullish, and 1 indifferent rating. The average 12-month price target among 7 analysts is $48.86, with a high of $60.00 and a low of $38.00. This target is a 3.06% decrease from the previous target of $50.40. Analyst ratings are based on financial statements, company meetings, and insider information, and are updated quarterly.

Portfolio Pulse from Benzinga Insights

November 15, 2023 | 7:00 pm